Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Concordia Healthcare Corp. T.CXR.R



TSX:CXR.R - Post by User

Comment by MrHuloton Mar 16, 2017 10:28pm
84 Views
Post# 25991614

RE:Future plans in the works.......

RE:Future plans in the works.......

Hey Cockroaches, no reaction to yesterday’s transcripts provided by Happy?

happyretirement - (3/15/2017 7:13:24 PM) 
Future plans in the works.......

"We have an additional 10 products that have already been approved or are awaiting regulatory approval in various countries. We anticipate that these 10 products once launched will compete in product areas with a current total IMS measured market value expected to be approximately $140 million".

"In addition, we have eight products under development that we anticipate we will launch in the next three years to five years. We anticipate that these eight products once launched will compete in product areas with a current total IMS measured market value expected to be in excess of $1 billion and includes several potential first to market or early to market opportunities for difficult to make products".

"Finally, we have already identified up to 14 additional products for potential development within our large network of external partners that we believe would compete in market that are currently estimated to be worth hundreds of millions of dollars more. That's when one adds the 10 products approved or awaiting approval to the eight products in development and the 14 products on our development radar, our current pipeline now totals 32 products that we believe will compete in IMS measured markets valued at approximately $1.5 billion".

GLTAL

<< Previous
Bullboard Posts
Next >>